Drug Hunting

Navigation of the current and future pipeline of the top ten biopharmaceutical companies
Smart due diligence of potential out-licensing candidates using the latest scientific knowledge and soft intelligence
Special emphasis on promising drug candidates in new disease indications or through new innovative combinations
Investor backed drug acquisition and development through proof-of-concept